Pubblicazioni

Evaluation of the Anti-Histoplasma capsulatum activity of Indole and Nitrofuran derivatives and their pharmacological safety in three-dimensional cell cultures

2022 - PHARMACEUTICS

Vaso, C. O.; Bila, N. M.; Pandolfi, F.; De Vita, D.; Bortolami, M.; Bonatti, J. L. C.; de Moraes Silva, R. A.; Goncalves, L. N. C.; Tudino, V.; Costi, R.; Di Santo, R.; Mendes-Giannini, M. J. S.; Costa-Orlandi, C. B.; Scipione, L.; Fusco-Almeida, A. M.

New 1 H âindoleâ2,3âdione 3âthiosemicarbazones with 3âsulfamoylphenyl moiety as selective carbonic anhydrase inhibitors

2022 - ARCHIV DER PHARMAZIE

Eraslanâelma, PÄ±nar; Akdemir, Atilla; Berrino, Emanuela; BozdaÄ, Murat; Supuran, Claudiu T.; KaralÄ±, NilgÃ¼n

CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme

2021 - EUROPEAN JOURNAL OF PHARMACOLOGY

Daniele, S.; La Pietra, V.; Piccarducci, R.; Pietrobono, D.; Cavallini, C.; D'Amore, V. M.; Cerofolini, L.; Giuntini, S.; Russomanno, P.; Puxeddu, M.; Nalli, M.; Pedrini, M.; Fragai, M.; Luchinat, C.; Novellino, E.; Taliani, S.; La Regina, G.; Silvestri, R.; Martini, C.; Marinelli, L.

Palladium-catalyzed C12-selective direct arylation of [1,2-c] quinazolin-6(5H)-ones

2019 - SYNTHESIS

Arcadi, Antonio; Cacchi, Sandro; Fabrizi, Giancarlo; Fochetti, Andrea; Ghirga, Francesca; Goggiamani, Antonella; Iazzetti, Antonia; Marinelli, Fabio

Nintedanib for systemic sclerosis-associated interstitial lung disease

2019 - NEW ENGLAND JOURNAL OF MEDICINE

Distler, O.; Highland, K. B.; Gahlemann, M.; Azuma, A.; Fischer, A.; Mayes, M. D.; Raghu, G.; Sauter, W.; Girard, M.; Alves, M.; Clerisme-Beaty, E.; Stowasser, S.; Tetzlaff, K.; Kuwana, M.; Maher, T. M.; Riccieri, V

Palladium-Catalyzed Cascade Approach to 12-(Aryl)indolo[1,2- c ]quinÃÂazolin-6(5 H )-ones

2018 - SYNTHESIS

Arcadi, Antonio; Cacchi, Sandro; Fabrizi, Giancarlo; Ghirga, Francesca; Goggiamani, Antonella; Iazzetti, Antonia; Marinelli, Fabio

Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer

2018 - CANCER TREATMENT REVIEWS

Musella, Angela; Bardhi, Erlisa; Marchetti, Claudia; Vertechy, Laura; Santangelo, Giusi; Sassu, Carolina; Tomao, Federica; Rech, Francesco; D'Amelio, Renzo; Monti, Marco; Palaia, Innocenza; Muzii, Ludovico; Benedetti Panici, Pierluigi

Synthesis of indolo[1,2-c]quinazolines from 2-alkynylaniline derivatives through Pd-catalyzed indole formation/cyclization with N,N-dimethylformamide dimethyl acetal

2018 - BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY

Arcadi, A; Cacchi, S; Fabrizi, G; Ghirga, F; Goggiamani, A; Iazzetti, A; Marinelli, F

A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib

2015 - BIOCHEMICAL PHARMACOLOGY

Graziani, Grazia; Artuso, Simona; De Luca, Anastasia; Muzi, Alessia; Rotili, Dante; Scimeca, Manuel; Atzori, Maria Grazia; Ceci, Claudia; Mai, Antonello; Leonetti, Carlo; Levati, Lauretta; Bonanno, Elena; Tentori, Lucio; Caccuri, Anna Maria

ErbB-3 activation by NRG-1Î² sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)

2015 - ONCOTARGET

Prasetyanti, Pramudita R.; Capone, Emily; Barcaroli, Daniela; D'Agostino, Daniela; Volpe, Silvia; Benfante, Antonina; van Hooff, Sander; Iacobelli, Valentina; Rossi, Cosmo; Iacobelli, Stefano; Medema, Jan Paul; de Laurenzi, Vincenzo; Sala, Gianluca